Study of Anti-CD33 Chimeric Antigen Receptor-Expressing T Cells (CD33CART) in Children and Young Adults With Relapsed/Refractory Acute Myeloid Leukemia (clinicaltrials.gov) - May 14, 2024 - P1/2 | N=52 | Recruiting | Sponsor: Center for International Blood and Marrow Transplant Research | Active, not recruiting ➔ Recruiting | Trial primary completion date: Dec 2024 ➔ Dec 2029
Enrollment open • Trial primary completion date • Acute Myelogenous Leukemia • Hematological Malignancies • Leukemia • Oncology
|